Gilead Sciences, Inc. (GILD)
123.60
+2.26
(+1.86%)
USD |
NASDAQ |
Dec 11, 15:31
Gilead Sciences EPS Diluted (Quarterly): 2.434 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
| Merck & Co., Inc. | 2.316 |
| Pfizer Inc. | 0.6197 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.052B |
| Revenue (Quarterly) | 7.784B |
| Total Expenses (Quarterly) | 4.732B |
| Enterprise Value | 166.23B |
| Gross Profit Margin (Quarterly) | 79.84% |
| Profit Margin (Quarterly) | 39.21% |
| Earnings Yield | 5.22% |
| Operating Earnings Yield | 7.30% |
| Normalized Earnings Yield | 5.593 |